Navigation Links
InterMune Reports Results from Triple Combination Study of ITMN-191
Date:1/12/2009

The Phase 1b randomized, double-blind, placebo-controlled, 14-day triple combination study in treatment-naive patients chronically infected with HCV genotype 1 was designed to inform the dose selection and study design of the ITMN-191 Phase 2 program. The study objectives were to assess the safety, pharmacokinetic and viral kinetic effects of various doses and regimens of ITMN-191 for 14 days in combination with Pegasys and Copegus compared to treatment with Pegasys and Copegus alone. Patient follow-up continues for 30 days following the completion of study treatment.

INFORM-1 Progress (All-oral STAT-C study)

In November 2008, Roche, InterMune and Pharmasset initiated the first all-oral combination study of direct anti-virals in the absence of interferon or ribavirin, known as the INFORM-1 study. That study has completed the first dose cohort. Results of INFORM-1 are expected to be reported at a major medical conference in the second quarter of this year.

Conference Call and Webcast Details

InterMune will host a conference call today at 8:30 a.m. EST to discuss the results of the 14-day triple combination study of ITMN-191. Interested investors and others may participate in the conference call by dialing 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 80676348. A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 80676348.
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. InterMune to Present at Thomas Weisel Partners Healthcare Conference
2. Former InterMune CEO W. Scott Harkonen Indicted for Wire Fraud and FDA Violations
3. InterMune to Present at the 2008 Wachovia Healthcare Conference
4. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
5. LegalView Reports Traumatic Brain Injury Study Concluding Spirituality Increases Following Brain Damage
6. Allscripts Reports Fiscal 2009 Second Quarter Results
7. MDS Reports Final Fourth-Quarter 2008 Results
8. Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100
9. Cardium Reports on Exchange Listing With NYSE Alternext US
10. CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte Closes
11. Joint Commission Reports Positive Survey Results for CHA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... On March 19, 2015, at ... Lions wide receiver Herman Moore, hosted “Fighting Addiction ... substance abuse, treatment options and the recent changes ... pastors, ministers and bishops from local churches as ... , “Our ‘Fighting Addiction Together’ luncheon was informative ...
(Date:3/27/2015)... 2015 GenSight, the leading Enterprise Portfolio ... Fitzgerald, a former technology and financial executive to serve ... Chief Financial Officer. , Mr Fitzgerald was most recently ... backed by Amazon founder and CEO Jeff Bezos, Google ... to EverFi, he was a Senior Vice President at ...
(Date:3/27/2015)... WA (PRWEB) March 27, 2015 When ... can be hard to know where to begin. The ... experienced Seattle trucking accident attorney, offers accident victims a ... and legal assistance to ensure their personal injury claim ... begins by describing the first actions that should be ...
(Date:3/27/2015)... St. Paul, MN (PRWEB) March 27, 2015 ... first annual Minnesotans for Healthy Kids Coalition Lobby ... and the Statewide Health Improvement Program (SHIP). ... for the 2015 PE Bill SF343/HF498 which would ... benchmarks, require annual student assessments and other measures ...
(Date:3/27/2015)... Ontario (PRWEB) March 27, 2015 ... in the safe prescribing and utilization of medical ... joined Canada.MarijuanaDoctors.com’s network of doctors and clinics dedicated ... , MarijuanaDoctors.com, a trusted gateway for patients searching ... states and territories, recently launched their sub domain ...
Breaking Medicine News(10 mins):Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2
... made heart implanted inside him last month .This makes ... beat! ,“Heartmate II”, the mechanical heart was implanted inside ... a three-hour surgery on Nov. 23, 2006.This device,is expected to function ... balanced within a magnetic field. Before the surgery, the patient was ...
... difficulty making ends meet and most often end up selling ... study included 1,751 people.// ,People diagnosed with ... report to work regularly and at the same time face ... selling their homes. ,The Macmillan Cancer Support ...
... are not protected from attacks or stroke by taking a ... ,Folic acid or folate is one of the B Vitamins ... medical practitioners prescribe it to prevent cardiac problems. ... Health and Tropical Medicine, New Orleans led a research on ...
... causes cervical cancer as it affects the lining of the ... sexually.// ,Merck & Co. Inc.'s have recently launched ... been proven to prevent cervical cancer. ,The new ... rich countries but it is very doubtful how it would ...
... ,Long shifts done by doctors in the hospitals results// ... rested and well-trained doctors. ,An U.S study by ... working long shifts without rest have an increased risk (300 ... could be prevented. ,The study was based ...
... Deafness Research UK has suggested that certain Christmas toys are ... when 14 toys out of the 15 that// were tested, ... prescribed safety limits of 85 decibels. ,Among ... which included a mechanical toy machine gun, a plastic tommy ...
Cached Medicine News:Health News:Vaccines For Cervical Cancer Will Soon Be Available In Developing Nations 2Health News:Toy Story Turns Bitter-Christmas Toys, No Music to the Ears! 2
(Date:3/27/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is celebrating ... Complete Knee System. , ... year since Zimmer first introduced the NexGen knee system, with ... than five million implantations of the NexGen knee have taken ... NexGen knee demonstrates the importance of design innovation and component quality ...
(Date:3/27/2015)... 2015 XRpro Sciences, Inc., a provider ... development services which features high throughput transporter and ... financial results for the year ended December 31, ... of XRpro Sciences commented, "We have completed a ... stage to commercial stage in large part by ...
(Date:3/27/2015)... 27, 2015 Report Details  ... ophthalmic drug companies  What does the future ... industry ? Visiongain,s brand new report shows you potential ... there. Our 242-page report provides 185 tables, ... the industry and the future market prospects. Our new ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7
... Breast-Specific Gamma Imaging (BSGI) has been proven to be a ... in situ (DCIS), a difficult to diagnose breast cancer. BSGI ... independent of tissue density and discover very early stage cancers. ... the Radiological Society of North America (RSNA), BSGI is an ...
... , , TORONTO, Nov. 30 The Special ... "Company") (TSX: PTI) and JLL Partners, Inc. and its affiliate, ... Company and JLL have entered into a settlement agreement in ... , The settlement provides among other things that: , ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ 2Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3
... built to be the best stress treadmill ... quieter and more reliable than any competitor, ... safety and comfort of the patient. It ... features include a low profile deck, incredibly ...
... digitally-controlled drive system which eliminates many ... wear out. There are no motor ... fewer drive belts - resulting in ... can carry weights up to 400 ...
... PCE PC-Based Exercise ECG Systems offer clinical ... provide advanced database functionality for paperless storage. ... the Welch Allyn PCE Exercise ECG software ... test system. And with its ability to ...
... systems feature our internationally-acclaimed algorithm that ... algorithm has a proven record for ... situations; and it's just one of ... recognized market leader in the stress ...
Medicine Products: